Skip to content
Skip to footer

Back to McKesson.com Home

Business Services and Solutions

Our integrated approach combines expert advisory services and cutting-edge technology to help you overcome challenges, identify opportunities, and improve your pharmacy’s performance.

Explore
- Professional & Advisory Services
  
  Improve your pharmacy's business performance with McKesson's Professional & Advisory Services (P&AS). By leveraging deep industry knowledge and advanced analytics, we help you improve operations so you can achieve more for the business of pharmacy.
  
  Specialty and Infusion Solutions for Health Systems
  
  Specialty Pharmacy
  
  Payer Solutions
  
  340B Advisory
  
  340B Impact
  
  Contract Concierge
  
  Orphan Drug Support Program
- Additional Business Solutions
  
  Our extensive portfolio of business solutions empowers health system pharmacies to achieve more by improving operations and driving business growth. Leveraging technology-driven platforms and strategic guidance, we provide actionable insights to address critical challenges, including supply chain management, revenue cycle optimization, 340B drug pricing, and more.
  
  Macro Helix™/ RxO
  
  Class of Trade Optimization
  
  SupplyLogix®
  
  EnterpriseRx®
Pharmaceutical Products and Distribution

It's time to expect more from your pharmaceutical distributor. Let us provide the perspective, focus, and execution you need to help the business of pharmacy achieve more for the advancement of patient health. Our innovative distribution strategies and suite of pharmaceutical products empower your health system to focus on your commitment on advancing value-based care.

Explore
- Pharmaceutical Products
  
  Our expansive portfolio is designed to support the continuum of care, from groundbreaking biosimilar innovations and essential generics to life-changing orphan drugs and revolutionary cell and gene therapies. Additionally, our robust supply assurance strategies ensure that you can depend on a consistent and timely delivery of the medications your patients rely on.
  
  Biosimiliars
  
  Branded and Generic Products
  
  Orphan Drugs
  
  Cell, Gene, & Advanced Therapies
  
  Supply Assurance
- McKesson Plasma & Biologics
  
  As demand for specialty pharmaceuticals and biologics continues to rise and add complexity to the supply chain, we’re responding with new distribution strategies to seamlessly deliver. McKesson Plasma and Biologics offers customers an expansive portfolio of plasma-derived products, biologics and other specialty drugs at competitive prices from a single source that has deep experience in specialized patient care. 
- Ordering and Reporting
  
  McKesson's innovative ordering and reporting solutions are designed to help health systems achieve more for the business of pharmacy. Our comprehensive platforms allow your pharmacy to streamline operations, optimize inventory and make data-driven decisions.
  
  McKesson Enterprise Reporting & Analytics (ERA)
  
  Connect Ordering
  
  Rapid Returns
Industry News and Insights

Staying informed on the latest industry news and insights is critical in achieving more for the business of pharmacy. Within Prescribed Perspectives, you’ll find exclusive articles, podcasts, eBooks, research, and additional resources authored by our health system experts that can help your health system pharmacy with operational efficiency, cost-saving strategies, and more.

Explore
- Prescribed Perspectives Insights Center
  
  A dedicated resource for health system teams to access valuable industry insights and cost-saving strategies.
  
  Research
  
  Case Studies
  
  eBooks
  
  Industry Webinars
  
  View All
  
  Subscribe Now
- Our Authors
  
  With unique industry knowledge and first-hand experience across virtually all areas of health system pharmacy, our authors and experts are dedicated to helping you achieve more.
- Insights by Topic
  
  Get straight to the insights that matter most to your health system.
  
  C-Suite Considerations
  
  340B
  
  Specialty Pharmacy
  
  Supply Chain & Distribution
  
  MHS in the News
  
  View All
- Industry Conferences and Events
  
  Join us at upcoming healthcare and pharmacy conferences to connect with our industry-leading experts, gain valuable insights, discover innovative solutions, and participate in strategic discussions that advance the future of health system pharmacy.
Contact Health Systems

Ready to achieve more for the business of pharmacy? Contact us today to discover how McKesson's innovative business services and solutions can help improve your operations and drive financial success.

Contact Us Now
- Contact Health Systems
  
  Contact Us
  
  Communications Preference Center
- Industry Conferences and Events
  
  Join us at upcoming healthcare and pharmacy conferences to connect with our industry-leading experts, gain valuable insights, discover innovative solutions, and participate in strategic discussions that advance the future of health system pharmacy.

How Biosimilars Differ from Biologics in Cost and Benefits

Increased affordability of biosimilars may have an impact on healthcare systems.

By McKesson Health Systems Editorial Team

Date

August 01, 2022

By: McKesson Medical Surgical Editorial Team

Read time: 1 minute

An overview of biosimilars and how they compare to biologics

Health systems and clinics considering the adoption of biosimilars for treatment should understand and consider how they compare to biologics. Biosimilar products are therapies that have the same therapeutic value and potency as their biologic counterparts, the use of biosimilar drugs may save money for both patients and providers. Increased affordability of the biosimilars may also have a meaningful impact on the healthcare system.

To learn more, read What are biosimilars? How biosimilars differ from biologics in cost & benefits.

Subscribe Now

To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.

Related Stories

A glowing blue DNA double helix on a dark background with surrounding particles.

Expert Q&A: Overcoming Challenges in Operationalizing CGT Within Health Systems

McKesson’s Head of Cell, Gene, and Advanced Therapies discusses opportunities and challenges with CGT in the health system.

Group of business professionals walk and talk in a bright glass hallway, some holding folders and coffee, moving between offices.

Upcoming Event: THMA Pharmacy Growth Collaborative

Executive dialogue and peer-driven insights shaping the future of health system pharmacy

Two business professionals shake hands in a bright office while three colleagues stand behind them holding documents.

2026 Asembia Summit Highlights the Value of Connection Across Specialty, Data, and Partnerships

Engagement across customers, manufacturers, and partners reinforces the importance of collaboration in advancing specialty pharmacy

Microphone on a stand at a panel discussion, with seated speakers and gesturing hands out of focus in the background.

Optimizing Pharmaceutical Supply Chain and Inventory Management: Insights from Becker’s Healthcare Annual Meeting

Explore key takeaways and insights from our recent discussion with health system leaders.

IV infusion bag on a stand in the foreground, with two seated people in a clinical room in the background.

The Infusion Perfect Storm: A Defining Moment in Health System Infusion Strategy?

Health systems infusion services may be entering a period of accelerated transformation and the window for strategic repositioning could be narrowing. Are you ready?

People networking in a bright atrium, standing by glass railings and talking in small groups.

Upcoming Event: Navigating the Future of Specialty Pharmacy at AXS26

Connect with our industry leaders at Asembia to discover strategies to help you achieve more.

Five people seated around a conference table reviewing documents and charts during a meeting in a bright office.

Upcoming Event: Becker’s 16th Annual Meeting

McKesson leaders attending a C-suite roundtable on optimizing pharmaceutical supply chain and inventory management.

Four business professionals in a bright glass hallway, two standing and talking while others walk past, with city buildings visible through the windows.

Event Recap: 2026 340B Coalition Winter Conference Highlights

At this year's event, our experts engaged with health system leaders to address the growing need for strategic alignment and specialized support in 340B program management.

Close-up of an IV drip chamber with clear fluid flowing through tubing, with gloved hands and a clinical setting in the background.

Inside the Growth of Infusion Care: What’s Driving Demand—and How Health Systems Can Keep Pace

Empowering health systems to expect more from their infusion programs—and achieve more for every patient.

A pharmacist organizes prescription bottles on a rack

Four Key Aspects of Generic Drugs

Key aspects of generic drugs that support the case for wider adoption in health systems and beyond.

Related Tags